BCYC
Price
$7.16
Change
+$0.19 (+2.73%)
Updated
Sep 5 closing price
Capitalization
483.07M
54 days until earnings call
PPBT
Price
$0.66
Change
-$0.12 (-15.38%)
Updated
Sep 5 closing price
Capitalization
2.71M
Interact to see
Advertisement

BCYC vs PPBT

Header iconBCYC vs PPBT Comparison
Open Charts BCYC vs PPBTBanner chart's image
Bicycle Therapeutics
Price$7.16
Change+$0.19 (+2.73%)
Volume$177.42K
Capitalization483.07M
Purple Biotech
Price$0.66
Change-$0.12 (-15.38%)
Volume$3.22M
Capitalization2.71M
BCYC vs PPBT Comparison Chart in %
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. PPBT commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a StrongBuy and PPBT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BCYC: $7.16 vs. PPBT: $0.66)
Brand notoriety: BCYC and PPBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 66% vs. PPBT: 254%
Market capitalization -- BCYC: $483.07M vs. PPBT: $2.71M
BCYC [@Biotechnology] is valued at $483.07M. PPBT’s [@Biotechnology] market capitalization is $2.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whilePPBT’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • PPBT’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and PPBT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while PPBT’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 3 bearish.
  • PPBT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both BCYC and PPBT are a good buy in the short-term.

Price Growth

BCYC (@Biotechnology) experienced а -2.98% price change this week, while PPBT (@Biotechnology) price change was -66.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($483M) has a higher market cap than PPBT($2.71M). BCYC YTD gains are higher at: -48.857 vs. PPBT (-85.928). PPBT has higher annual earnings (EBITDA): -2.43M vs. BCYC (-240.81M). BCYC has more cash in the bank: 721M vs. PPBT (5.92M). PPBT has less debt than BCYC: PPBT (103K) vs BCYC (7.2M). BCYC has higher revenues than PPBT: BCYC (19.3M) vs PPBT (0).
BCYCPPBTBCYC / PPBT
Capitalization483M2.71M17,849%
EBITDA-240.81M-2.43M9,902%
Gain YTD-48.857-85.92857%
P/E RatioN/A0.00-
Revenue19.3M0-
Total Cash721M5.92M12,181%
Total Debt7.2M103K6,987%
FUNDAMENTALS RATINGS
BCYC vs PPBT: Fundamental Ratings
BCYC
PPBT
OUTLOOK RATING
1..100
1650
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
8998
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5018

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (19) in the null industry is in the same range as PPBT (22) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to PPBT’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as PPBT (100) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to PPBT’s over the last 12 months.

PPBT's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as BCYC (96) in the null industry. This means that PPBT’s stock grew similarly to BCYC’s over the last 12 months.

BCYC's Price Growth Rating (89) in the null industry is in the same range as PPBT (98) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to PPBT’s over the last 12 months.

BCYC's P/E Growth Rating (100) in the null industry is in the same range as PPBT (100) in the Pharmaceuticals Major industry. This means that BCYC’s stock grew similarly to PPBT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCPPBT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYESX189.35N/A
N/A
Rydex Energy Services A
FASDX17.87N/A
N/A
Fidelity Advisor Strategic Div & Inc A
FSCPX70.34N/A
N/A
Fidelity Select Consumer Discret Port
MAGRX32.19N/A
N/A
BlackRock Natural Resources Instl
MXJVX10.44N/A
N/A
Empower International Value Instl

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+2.73%
RPTX - BCYC
52%
Loosely correlated
N/A
XNCR - BCYC
50%
Loosely correlated
+2.15%
RLAY - BCYC
47%
Loosely correlated
+3.00%
RCUS - BCYC
43%
Loosely correlated
+5.45%
IDYA - BCYC
41%
Loosely correlated
+5.15%
More